Taking the fact that ST6Gal-I is significantly overexpressed in liver cancer, and its important role in tumor cell apoptosis, we aimed to determine whether its expression could impact the sensitivity of hepatocarcinoma cells to docetaxel. Here, ST6GAL1 is linked to liver cancer.